Corrigendum to "PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer"
Related Experiment Video
Updated: Oct 14, 2025

09:40
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
2.8K
Guang Li1, Guobing Liu2, Xuefeng Wang1
1Department of Obstetrics and Gynecology, Third Affiliated Hospital of Southern Medical University, Guangzhou, 510515 Guangdong Province, China.
Biomed Research International
|November 2, 2021
Abstract:
[This corrects the article DOI: 10.1155/2021/5512340.].

